USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway

被引:34
作者
Diao, Wenjing [1 ]
Guo, Qisang [1 ]
Zhu, Caiying [1 ]
Song, Yu [1 ]
Feng, Hua [1 ]
Cao, Yuankui [1 ]
Du, Ming [1 ]
Chen, Huifen [2 ]
机构
[1] Fudan Univ, Obstet & Gynecol Hosp, Med Ctr Cerv Dis, Fangxie Rd 419, Shanghai 200011, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Lab Med, Changle Rd 536, Shanghai 200040, Peoples R China
关键词
Cervical cancer; USP18; AKT; Proliferation; Apoptosis; UBIQUITIN; METASTASIS; EXPRESSION; GROWTH; UBP43; ALPHA;
D O I
10.1186/s12885-020-07241-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe deubiquitinating (DUB) enzyme ubiquitin-specific protease 18 (USP18), also known as UBP43, is an ubiquitin-specific protease linked to several human malignancies. However, USP18's underlying function in human cervical cancer remains unclear. In the current study, we aimed to analyse the role of USP18 and its signalling pathways in cervical cancer.MethodsQuantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemical staining were performed to analyse USP18 levels in cervical cancer and matched to adjacent normal tissues. Moreover, RNA interference (RNAi) and lentiviral-mediated vector transfections were performed to silence and overexpress USP18, respectively, in cervical cancer cells. Further, Cell Counting Kit-8 (CCK-8) and Annexin V/PI staining assays were used to assess its biological function in cell proliferation and apoptosis, respectively. A xenograft model was used to examine USP18's function in vivo.ResultsThe present findings demonstrated that USP18 was overexpressed in cervical cancer specimens and cell lines. Silencing USP18 in SiHa and Caski cervical cancer cell lines inhibited cell proliferation, induced apoptosis, and promoted cleaved caspase-3 expression. In contrast, USP18 overexpression showed the opposite effects in human HcerEpic cells. A Gene Set Enrichment Analysis revealed that USP18 was enriched in the PI3K/AKT signalling pathway in cervical cancer. Hence, the PI3K/AKT inhibitor LY294002 was used to determine the relationship between USP18 and AKT in cervical cancer cells. Importantly, LY294002 significantly abolished the effects of USP18 overexpression in cervical cancer cells. In vivo, USP18 silencing inhibited human cervical cancer cells' tumorigenicity.ConclusionsThe current study indicates that USP18 is an oncogenic gene in cervical cancer. Our findings not only deepened the understanding of USP18's biological function in cervical cancer pathogenesis, but we also provided novel insight for cervical cancer therapy.Trial registrationRetrospectively registered.
引用
收藏
页数:9
相关论文
共 25 条
[1]   PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives [J].
Asati, Vivek ;
Mahapatra, Debarshi Kar ;
Bharti, Sanjay Kumar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 :314-341
[2]   Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10 [J].
Burkart, Christoph ;
Arimoto, Kei-ichiro ;
Tang, Tingdong ;
Cong, Xiuli ;
Xiao, Nengming ;
Liu, Yun-Cai ;
Kotenko, Sergei V. ;
Ellies, Lesley G. ;
Zhang, Dong-Er .
EMBO MOLECULAR MEDICINE, 2013, 5 (07) :1035-1050
[3]   Downregulation of USP18 inhibits growth and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma cells by suppressing BCL2L1 [J].
Cai, Jing ;
Liu, Tiande ;
Jiang, Xiaoliu ;
Guo, Changkuo ;
Liu, Anwen ;
Xiao, Xinlan .
EXPERIMENTAL CELL RESEARCH, 2017, 358 (02) :315-322
[4]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[5]   Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review [J].
Costa, Ricardo L. B. ;
Han, Hyo Sook ;
Gradishar, William J. .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) :397-406
[6]   Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer [J].
Ebrahimi, Safieh ;
Hosseini, Mina ;
Shahidsales, Soodabeh ;
Maftouh, Mina ;
Ferns, Gordon A. ;
Ghayour-Mobarhan, Majid ;
Hassanian, Seyed Mahdi ;
Avan, Amir .
CURRENT MEDICINAL CHEMISTRY, 2017, 24 (13) :1321-1331
[7]   Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia [J].
Guo, Yongli ;
Dolinko, Andrey V. ;
Chinyengetere, Fadzai ;
Stanton, Bruce ;
Bomberger, Jennifer M. ;
Demidenko, Eugene ;
Zhou, Da-Cheng ;
Gallagher, Robert ;
Ma, Tian ;
Galimberti, Fabrizio ;
Liu, Xi ;
Sekula, David ;
Freemantle, Sarah ;
Dmitrovsky, Ethan .
CANCER RESEARCH, 2010, 70 (23) :9875-9885
[8]   Ubiquitin and ubiquitin-like proteins in cancer pathogenesis [J].
Hoeller, Daniela ;
Hecker, Christina-Maria ;
Dikic, Ivan .
NATURE REVIEWS CANCER, 2006, 6 (10) :776-788
[9]   p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis [J].
Jiang, Chao ;
Xu, Rui ;
Li, Xiao-Xing ;
Wang, Yan-Yan ;
Liang, Wen-Qian ;
Zeng, Ju-Deng ;
Zhang, Shan-Shan ;
Xu, Xiao-Yi ;
Yang, Yang ;
Zhang, Mei-Yin ;
Wang, Hui-Yun ;
Zheng, X. F. Steven .
CELL CYCLE, 2017, 16 (18) :1673-1682
[10]  
Khan SR, 2016, Q J NUCL MED MOL IM, V60, P77